申请人:Andries Koenraad Jozef Lodewijk Marcel
公开号:US20100197727A1
公开(公告)日:2010-08-05
Use of a compound for the manufacture of a medicament for the treatment of a bacterial infection provided that the bacterial infection is other than a Mycobacterial infection, said compound being a compound of formula (Ia) or (Ib)
a N-oxide, a tautomeric form or a stereochemically isomeric form thereof wherein A
−
is a counter ion; R
1
is hydrogen, halo, haloalkyl, cyano, hydroxy, Ar, Het, alkyl, alkyloxy, alkylthio, alkyloxyalkyl, alkylthioalkyl, Ar-alkyl or di(Ar)alkyl; p is 1 to 4; R
2
is hydrogen, hydroxy, mercapto, alkyloxy, alkyloxyalkyloxy, alkylthio, mono or di(alkyl)amino or
wherein Y is CH
2
, O, S, NH or N-alkyl; R
3
is alkyl, Ar, Ar-alkyl, Het or Het-alkyl; q is 0 to 4; R
4
and R
5
each independently are hydrogen, alkyl or benzyl; or R
4
and R
5
may be taken together including the N to which they are attached; R
6
is hydrogen, halo, haloalkyl, hydroxy, Ar, alkyl, alkyloxy, alkylthio, alkyloxyalkyl, alkylthioalkyl, Ar-alkyl or di(Ar)alkyl; or two vicinal R
6
radicals may be taken together to form —CH═CH—CH═CH—; r is 1 to 5; R
7
is hydrogen, alkyl, Ar or Het; R
8
is hydrogen or alkyl; R
9
is oxo; or R
8
and R
9
taken together form —CH═CH—N═; R
10
is alkyl, alkylcarbonyl, Ar, Ar-alkyl, Ar-carbonyl, Het
1
-alkyl or Het
1
-carbonyl.